Filter
964
Filtered Results: 964
Text search:
M.
Hammer
Featured
Recommendations
61
New Publications
227
Language
Document type
No document type
526
Studies & Reports
232
Guidelines
95
Manuals
49
Strategic & Response Plan
35
Fact sheets
10
Training Material
7
Situation Updates
6
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
Global
35
India
34
Kenya
24
Africa
24
Western and Central Europe
23
Sierra Leone
19
South Africa
18
Uganda
18
Malawi
17
Latin America and the Carribbean
17
Bangladesh
17
Nepal
16
Ethiopia
15
Nigeria
14
Congo, Democratic Republic of
14
Liberia
14
Zambia
13
Myanmar / Burma
13
Syria
12
Tanzania
12
Rwanda
11
Germany
11
Ghana
9
Mozambique
9
South–East Asia Region
9
Eastern Europe
9
Brazil
9
Ukraine
8
Asia
8
Russia
8
Philippines
7
Guinea
7
Indonesia
7
Lesotho
6
Cameroon
6
Eastern Europe and Central Asia
6
Namibia
6
Zimbabwe
5
East and Southern Africa
5
South Sudan
5
Pakistan
5
West and Central Africa
4
Argentina
4
Central African Republic
4
Botswana
4
Eswatini/ Swaziland
4
Chile
3
Burkina Faso
3
Venezuela
3
Middle East and North Africa
3
Western Pacific Region
3
Lebanon
3
Sudan
3
Yemen
3
Madagascar
3
Colombia
2
Thailand
2
Turkey
2
Albania
2
Senegal
2
USA
2
Haiti
2
Cambodia
2
Portugal
2
Spain
2
Vietnam
2
North Macedonia
1
Tajikistan
1
Switzerland
1
Mexico
1
Benin
1
China
1
Canada
1
Singapore
1
Kyrgyzstan
1
Burundi
1
Morocco
1
Qatar
1
Italy
1
Hungary
1
Jordan
1
Paraguay
1
North America
1
Jamaica
1
France
1
United Kingdom
1
Norway
1
Sri Lanka
1
Egypt
1
Georgia
1
Mali
1
Angola
1
Chad
1
Iraq
1
Somalia
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
322
Public Health
58
Clinical Guidelines
48
Key Resources
40
Women & Child Health
33
Capacity Building
14
Pharmacy & Technologies
8
Toolboxes
Mental Health
94
COVID-19
79
HIV
77
Planetary Health
63
TB
57
Disability
38
AMR
32
NCDs
27
Global Health Education
24
Conflict
23
Caregiver
22
Ebola
21
NTDs
21
Natural Hazards
20
Refugee
17
Health Financing Toolbox
16
Rapid Response
15
Pharmacy
12
Specific Hazards
9
Polio
6
Social Ethics
4
Zika
4
Cholera
2
Health Financing
1
This collection of case studies on risk communication and community engagement (RCCE) from 18 different country/area level public health partners in the WHO European Region provides evidence of numerous results achieved and lessons learned since the start of the COVID-19 pandemic. RCCE has not...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
The power of the Global Drug Policy Index lies in its key objective: to score and
rank how countries are faring in different areas of drug policy as identified in the
UN report ‘What we have learned over the last ten years: A summary of knowledge
acquired and produced by the UN system on drug-r...
Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572
The world is not on track to end the AIDS pandemic. New infections are rising and AIDS deaths are continuing in too many communities. This report reveals why: inequalities are holding us back. In frank terms, the report calls the world’s attention to the painful reality that dangerous inequalities...
WHO’s sentinel surveys of acquired HIV resistance to dolutegravir among people receiving dolutegravir-containing antiretroviral therapy is intended for easy and frequent implementation. Results from sentinel surveys provide insight into the prevalence and year-over-year trends of dolutegravir resi...
The results of the report clearly show that in 2020, a year dominated by the emergence of COVID-19 and its associated health and economic crises, governments around the world rose to the challenge. Sharp increases in government spending on health at all country income levels underpinned the rise in ...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
Despite the significant role of vector control in national leishmaniasis control programmes, the programmatic community perceives vector control as the weakest component of leishmaniasis control strategies in terms of resources, scientific evidence of the usefulness of interventions and capacity for...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
This Handbook is primarily for educators, to help them learn about mental health issues and better support them in educational environments. The Handbook aims to provide training to teachers, administrators, and people involved in the education of primary school children about the implementation of ...
Countries are making progress toward the global goal of 95% of people living with HIV knowing their status by 2025. However, considerable gaps remain in achieving these goals globally. Men in high HIV burden settings and men from key populations in all settings are consistently less likely to know t...
Les pays progressent vers la réalisation de l’objectif mondial tendant à ce que, d’ici 2025, 95 pour cent des personnes qui vivent avec le VIH connaissent leur statut sérologique. Cependant, en 2020, on estimait encore à 6 millions le nombre de personnes séropositives non diagnostiquées da...
Les pays progressent vers la réalisation de l’objectif mondial tendant à ce que, d’ici 2025, 95 pour cent des personnes qui vivent avec le VIH connaissent leur statut sérologique. Cependant, en 2020, on estimait encore à 6 millions le nombre de personnes séropositives non diagnostiquées da...
Leptospirosis, a spirochaetal zoonosis, occurs in diverse epidemiological settings and affects vulnerable populations, such as rural subsistence farmers and urban slum dwellers. Although leptospirosis is a life-threatening disease and recognized as an important cause of pulmonary haemorrhage syndrom...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, health costs and social stigmatization of sufferers. ...
